# Prospective multicEntric NonranDomized Registry

Study · id `cardio:ct-nct02496169` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02496169](<https://clinicaltrials.gov/study/NCT02496169>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02496169

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 400 participants.

## Technical summary

Registry record NCT02496169. Non-randomized; no masking; primary purpose treatment. Start 2015-07 (registry gives no type); primary completion 2016-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 400 participants (planned count; ClinicalTrials.gov record NCT02496169, source copy `cardio:ctgov-nct02496169-2015-07-14`, retrieved 2026-10-26)
- Start date: 2015-07 (registry gives no type) (ClinicalTrials.gov record NCT02496169, source copy `cardio:ctgov-nct02496169-2015-07-14`, retrieved 2026-10-26)
- Primary completion: 2016-12 (anticipated) (ClinicalTrials.gov record NCT02496169, source copy `cardio:ctgov-nct02496169-2015-07-14`, retrieved 2026-10-26)
- Completion: 2017-12 (anticipated) (ClinicalTrials.gov record NCT02496169, source copy `cardio:ctgov-nct02496169-2015-07-14`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02496169-2015-07-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: Prospective multicEntric NonranDomized Registry
- Acronym: ExPEND
- Condition: Coronary Artery Disease
- Intervention (Device): eucaLimus
- Lead sponsor: Eucatech AG
- Lead sponsor class: INDUSTRY
- Collaborator: CERES GmbH
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)

## Provenance

Content hash: 8c13bbc0debd66d3d84f602bacaa1c19c3c727c1d1b1fc648e867d0b220cd06d
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
